Dr. Markus Britschgi

Angestellt, Senior Principal Scientist, Roche in Switzerland

Basel, Schweiz

Fähigkeiten und Kenntnisse

Drug Discovery
neurodegeneration
Parkinson's disease
Alzheimer's disease
translational medicine/diagnostics
Drug Development
biomarker of neurodegeneration
neuroimmunology
Immunology
neuroinflammation
neuroscience
aging
mouse models of neurodegeneration
proteomics
microarray analysis
bionetworks analysis
systems biology

Werdegang

Berufserfahrung von Markus Britschgi

  • Bis heute 7 Jahre und 8 Monate, seit Okt. 2016

    Senior Principal Scientist

    Roche in Switzerland

    Labhead and Preclinical Project Leader Neuroimmunology/Neurodegeneration; Reseach Lead in Development Team

  • 3 Jahre, Okt. 2013 - Sep. 2016

    Principal Scientist, Neurodegeneration and Neuroimmunology

    F. Hoffmann-La Roche AG

    Project Leader and Lab Head in preclinical drug and biomarker discovery for age-related neurodegenerative disorders

  • 4 Jahre und 1 Monat, Aug. 2009 - Aug. 2013

    Senior Scientist / Neuroimmunologist

    Hoffmann-La Roche

  • 11 Monate, Sep. 2008 - Juli 2009

    Instructor

    Stanford University School of Medicine, Neurology and Neurological Sciences

    Research on interactions of immune with nervous system in aging, Alzheimer's disease, and frontotemporal dementia (90%). Teaching and training students, postdocs and technicians (10%).

  • 5 Jahre und 4 Monate, Juni 2003 - Sep. 2008

    PhD, postdoctoral fellow, researcher

    Stanford University - Dept. of Neurology and Neurosciences

  • 10 Monate, Aug. 2002 - Mai 2003

    Research Associate

    Univeristy of Bern

  • 3 Jahre und 9 Monate, Dez. 1998 - Aug. 2002

    PhD student

    University of Bern

    PhD student in immunology (T cell mediated drug allergies)

Ausbildung von Markus Britschgi

  • 5 Jahre und 4 Monate, Juni 2003 - Sep. 2008

    Neuro-Immune interactions in the brain and periphery

    Stanford University (California/USA)

    Neuro-immune interaction in Alzheimer's disease, dementia and aging; detection of soluble blood proteins as biomarkers for dementia

  • 3 Jahre und 9 Monate, Dez. 1998 - Aug. 2002

    Immunology

    University of Bern, Switzerland

    T-cell mediated drug allergies; lymphocyte and blood cell characterization; FACS analysis; ELISA; cytotox assays; proliferation assays

  • 1996 - 1997

    Biochemistry

    University of Fribourg/Université de Fribourg, Switzerland

Sprachen

  • Deutsch

    -

  • Englisch

    -

  • Französisch

    -

21 Mio. XING Mitglieder, von A bis Z